Treatment of Malignant Pheochromocytomas With 131-I Metaiodobenzylguanidine and Chemotherapy

Article Properties
Cite
Sisson, James C., et al. “Treatment of Malignant Pheochromocytomas With 131-I Metaiodobenzylguanidine and Chemotherapy”. American Journal of Clinical Oncology, vol. 22, no. 4, 1999, pp. 364-70, https://doi.org/10.1097/00000421-199908000-00008.
Sisson, J. C., Shapiro, B., Shulkin, B. L., Urba, S., Zempel, S., & Spaulding, S. (1999). Treatment of Malignant Pheochromocytomas With 131-I Metaiodobenzylguanidine and Chemotherapy. American Journal of Clinical Oncology, 22(4), 364-370. https://doi.org/10.1097/00000421-199908000-00008
Sisson JC, Shapiro B, Shulkin BL, Urba S, Zempel S, Spaulding S. Treatment of Malignant Pheochromocytomas With 131-I Metaiodobenzylguanidine and Chemotherapy. American Journal of Clinical Oncology. 1999;22(4):364-70.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Treatment of Micronodular Lung Metastases of Papillary Thyroid Cancer: Are the Tumors too Small for Effective Irradiation from Radioiodine? Thyroid
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 11 1998
Two Cases of Malignant Pheochromocytoma Treated with Cyclophosphamide, Vincristine and Dacarbazine in a Combined Chemotherapy. Endocrine Journal
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 12 1996
10.1007/BF03165018 Annals of Nuclear Medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
 1994
Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine Nuclear Medicine Communications
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
 25 1993
10.1007/BF03345808 Journal of Endocrinological Investigation
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 1992
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)7
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology7
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine4
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens4
Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases3
Science: Biology (General)3
Science: Chemistry: Organic chemistry: Biochemistry3
Medicine: Internal medicine1
The category Medicine: Medicine (General) 7 is the most frequently represented among the references in this article. It primarily includes studies from Journal of Endocrinological Investigation and Cancer. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma Seminars in Nuclear Medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
 4 2023
I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paraganglioma

 Nuklearmedizin - NuclearMedicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
 1 2022
Jugular Paraganglioma Presenting with a Tumor Thrombus Extending from Posterior Fossa to Right Atrium and Multiple Skeletal Metastases

 Current Medical Imaging Reviews
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
 2022
ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy Journal of the ICRU 55 2021
Radiopharmaceutical therapy in cancer: clinical advances and challenges Nature Reviews Drug Discovery
  • Technology: Chemical technology: Biotechnology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 348 2020
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)39
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens12
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine12
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology9
Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases9
Medicine: Surgery6
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology5
Science: Biology (General)4
Science: Chemistry: Organic chemistry: Biochemistry4
Medicine: Therapeutics. Pharmacology3
Medicine: Public aspects of medicine: Toxicology. Poisons3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system3
Science: Science (General)3
Medicine2
Medicine: Internal medicine2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system2
Technology: Chemical technology: Biotechnology1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system1
Medicine: Surgery: Orthopedic surgery1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry1
Agriculture: Animal culture: Veterinary medicine1
Agriculture: Plant culture1
Agriculture: Animal culture1
Medicine: Pediatrics1
Medicine: Pathology1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
The category Medicine: Medicine (General) 39 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Radioisotope diagnosis and therapy of malignant pheochromocytoma and was published in 2001. The most recent citation comes from a 2023 study titled Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma. This article reached its peak citation in 2012, with 7 citations. It has been cited in 48 different journals, 4% of which are open access. Among related journals, the Seminars in Nuclear Medicine cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year